1220644

Xinmin Yu, MD — FEI 3019956302

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 15, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hangzhou (China)

Additional Details

Clinical Investigator (CI)